田中淳

タナカアツシ | Tanaka Atsushi

所属機関・部署：

研究分野 (7件)：腫瘍診断、治療学 , 腫瘍生物学 , 実験病理学 , 人体病理学 , 分子生物学 , システムゲノム科学 , ゲノム生物学

研究キーワード (12件)：インタラクトーム , 患者リスク層別化 , 治療標的探索 , バイオインフォマティクス , 膵腫瘍 , 軟部肉腫 , 消化器腫瘍 , 人体病理学 , マルチオミクス統合解析 , プロテオーム解析 , ゲノム解析 , 発現解析

競争的資金等の研究課題 (1件)：

論文 (14件)：

Makiko Ogawa, Atsushi Tanaka, Kei Namba, Jinru Shia, Julia Y. Wang, Michael H. A. Roehrl. Tumor stromal nicotinamide N-methyltransferase overexpression as a prognostic biomarker for poor clinical outcome in early-stage colorectal cancer. Scientific Reports. 2022. 12. 1
Jamal K. Benhamida, Monika Vyas, Atsushi Tanaka, Lu Wang, Armita Bahrami, Kerem Ozcan, Olca Basturk, Liliana Villafania, Douglas A. Mata, Tony El Jabbour, et al. Pancreatoblastomas and mixed and pure acinar cell carcinomas share epigenetic signatures distinct from other neoplasms of the pancreas. Modern Pathology. 2022. 35. 7. 956-961
Makiko Ogawa, Atsushi Tanaka, Kei Namba, Jinru Shia, Julia Y. Wang, Michael H. Roehrl. Early-Stage Loss of GALNT6 Predicts Poor Clinical Outcome in Colorectal Cancer. Frontiers in Oncology. 2022. 12
Tsuyoshi Hamada, Hiroki Oyama, Yousuke Nakai, Minoru Tada, Hideo Koh, Keisuke Tateishi, Junichi Arita, Ryunosuke Hakuta, Hideaki Ijichi, Kazunaga Ishigaki, et al. ABO Blood Group and Risk of Pancreatic Carcinogenesis in Intraductal Papillary Mucinous Neoplasms. Cancer Epidemiology, Biomarkers & Prevention. 2021. 30. 5. 1020-1028
Atsushi Tanaka, Julia Y Wang, Jinru Shia, Yihua Zhou, Makiko Ogawa, Ronald C Hendrickson, David S Klimstra, Michael H Roehrl. DEAD-box RNA helicase protein DDX21 as a prognosis marker for early stage colorectal cancer with microsatellite instability. Scientific reports. 2020. 10. 1. 22085-22085

MISC (14件)：

Makiko Ogawa, Atsushi Tanaka, Lingxin Zhang, Julia Wang, Ronald Hendrickson, David Klimstra, Meera Hameed, Michael Roehrl. Towards Biomarkers and Therapeutic Targets for Dedifferentiated Chondrosarcoma Discovered by Fourier Transform Mass Spectrometry Proteomics. MODERN PATHOLOGY. 2020. 33. SUPPL 2. 74-75
Atsushi Tanaka, Makiko Ogawa, Julia Wang, Ronald Hendrickson, David Klimstra, Michael Roehrl. Deep Proteomics of Colorectal Cancer Liver Metastases Uncovers New Tumor Subtypes and Therapeutic Targets. MODERN PATHOLOGY. 2020. 33. SUPPL 2. 777-777
Atsushi Tanaka, Makiko Ogawa, Julia Wang, Ronald Hendrickson, David Klimstra, Michael Roehrl. Deep Proteomics of Diffuse-Type Gastric Cancer Uncovers New Therapeutic Targets and Accelerates Drug Repositioning. MODERN PATHOLOGY. 2020. 33. SUPPL 2. 776-777
Atsushi Tanaka, Yihua Zhou, Ronald Hendrickson, Julia Wang, Michael H. A. Roehrl. Deep Proteomics of Colorectal Cancer Liver Metastases Uncovers Prognostic Factors and Highly Promising Therapeutic Targets. MODERN PATHOLOGY. 2019. 32
Yihua Zhou, Atsushi Tanaka, Ronald Hendrickson, Julia Wang, Michael H. A. Roehrl. Developing a Robust Sample Preparation Procedure for Deep Fourier-Transform Mass Spectrometric Profiling of Formalin-Fixed Paraffin-Embedded Clinical Tissue Specimens. MODERN PATHOLOGY. 2019. 32

講演・口頭発表等 (14件)：

Deep Proteomics of Diffuse-Type Gastric Cancer Uncovers New Therapeutic Targets and Accelerates Drug Repositioning
(MODERN PATHOLOGY 2020)
Deep Proteomics of Colorectal Cancer Liver Metastases Uncovers New Tumor Subtypes and Therapeutic Targets
(MODERN PATHOLOGY 2020)
Towards Biomarkers and Therapeutic Targets for Dedifferentiated Chondrosarcoma Discovered by Fourier Transform Mass Spectrometry Proteomics
(MODERN PATHOLOGY 2020)
Understanding the Metastatic Process by Deep Proteomic Analysis of Primary Colon Cancers and Matched Liver Metastases using Clinical FFPE Tissues
(MODERN PATHOLOGY 2019)
Deep Proteomics of Gastrointestinal Cancers Can Distinguish Tumor Location, Histology, and New Post-Genomic Subtypes
(MODERN PATHOLOGY 2019)

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

田中 淳